High-frequency oscillatory ventilation is not associated with increased risk of neuropathology compared with positive pressure ventilation: a preterm primate model.
High-frequency oscillatory ventilation (HFOV) may improve pulmonary outcome in very preterm infants, but the effects on the brain are largely unknown. We hypothesized that early prolonged HFOV compared with low volume positive pressure ventilation (LV-PPV) would not increase the risk of delayed brain growth or injury in a primate model of neonatal chronic lung disease. Baboons were delivered at 127 +/- 1 d gestation (dg; term approximately 185 dg), ventilated for 22-29 d with either LV-PPV (n = 6) or HFOV (n = 5). Gestational controls were delivered at 153 dg (n = 4). Brains were assessed using quantitative histology. Body, brain, and cerebellar weights were lower in both groups of prematurely delivered animals compared with controls; the brain to body weight ratio was higher in HFOV compared with LV-PPV, and the surface folding index was lower in the LV-PPV compared with controls. In both ventilated groups compared with controls, there was an increase in astrocytes and microglia and a decrease in oligodendrocytes (p < 0.05) in the forebrain and a decrease in cerebellar granule cell proliferation (p < 0.01); there was no difference between ventilated groups. LV-PPV and HFOV ventilation in prematurely delivered animals is associated with decreased brain growth and an increase in subtle neuropathologies; HFOV may minimize adverse effects on brain growth.
Loeliger
Michelle
M
Anatomy and Cell Biology, University of Melbourne, Victoria, Australia.
Inder
Terrie E
TE
Shields
Amy
A
Dalitz
Penelope
P
Cain
Sarah
S
Yoder
Bradley
B
Rees
Sandra M
SM
D000818:Animals; D001253:Astrocytes / Q000473:pathology; D001835:Body Weight; D001921:Brain / Q000254:growth & development / Q000473:pathology; D001927:Brain Diseases / Q000209:etiology / Q000473:pathology*; D049109:Cell Proliferation; D004195:Disease Models, Animal; D005260:Female; D006612:High-Frequency Ventilation / Q000379:methods*; D008171:Lung Diseases / Q000473:pathology*; D008297:Male; D009336:Necrosis; D009836:Oligodendroglia / Q000378:metabolism; D010215:Papio; D011323:Primates; D012306:Risk
J Neuropathol Exp Neurol. 2009 Jun;68(6):605-15
19458549
J Pediatr. 2003 Aug;143(2):171-9
12970628
Pediatr Res. 2007 May;61(5 Pt 1):552-8
17413862
Pediatrics. 2006 Oct;118(4):1640-53
17015557
Arch Dis Child Fetal Neonatal Ed. 2005 Nov;90(6):F466-73
15941826
Glia. 2005 Aug 15;51(3):229-34
15800897
Pediatrics. 2007 Apr;119(4):e860-5
17339385
Am J Respir Crit Care Med. 1999 Oct;160(4):1333-46
10508826
Arch Neurol. 1993 May;50(5):501-5
8489407
Pediatrics. 2001 Feb;107(2):363-72
11158471
Cochrane Database Syst Rev. 2007 Jul 18;(3):CD000104
17636590
J Mol Med (Berl). 1997 Mar;75(3):165-73
9106073
Nature. 1997 Jan 23;385(6614):313-8
9002514
N Engl J Med. 2002 Aug 29;347(9):633-42
12200550
Glia. 2005 Jan 15;49(2):161-76
15472994
Neuroscience. 2002;112(4):977-91
12088755
Arch Dis Child Fetal Neonatal Ed. 2006 Sep;91(5):F320-6
16690640
N Engl J Med. 2005 Jan 6;352(1):9-19
15635108
Pediatrics. 2008 Nov;122(5):e1014-21
18977951
Ultrasound Obstet Gynecol. 2005 Apr;25(4):372-7
15791694
Am Rev Respir Dis. 1988 May;137(5):1185-92
3195813
Am J Respir Crit Care Med. 2000 Nov;162(5):1867-76
11069828
N Engl J Med. 1989 Jan 12;320(2):88-93
2643039
J Neuropathol Exp Neurol. 2004 Dec;63(12):1297-309
15624766
Pediatrics. 2005 Mar;115(3):688-95
15741373